Skip to main content
. Author manuscript; available in PMC: 2010 Jan 12.
Published in final edited form as: J Alzheimers Dis. 2008 Apr;13(3):323–331. doi: 10.3233/jad-2008-13309

Figure 2.

Figure 2

(A) Immediate and (B) delayed list learning scores for memory-impaired adults with (E4+) and without (E4−) the APOE-ε4 allele. The memory-impaired/ε4− group showed maximal benefit at the 20 IU dose relative to the memory-impaired/ε4+ group (ps=0.0637and 0.0416 for between group comparisons for immediate and delayed recall).